98%
921
2 minutes
20
Background: Early results have illustrated the multiportal robotic approach to be safe and oncologically efficacious in the treatment of thoracic malignancies. Industry leaders have improved upon the lessons learned during the early multiportal studies and have now come to establish the feasibility of the biportal, and subsequently the uniportal robotic-assisted approach, all in an effort to offer patients equivalent or better outcomes with less surgical trauma. No current, coherent body of evidence currently exists outlining the early-term outcomes of patients undergoing uniportal robotic-assisted thoracic surgery. This systematic review and meta-analysis sought to clarify the early-phase outcomes of these patients.
Methods: An electronic search of four databases was performed to identify relevant studies outlining the immediate post-operative outcomes of patients undergoing uniportal robotic-assisted thoracic surgeries. The primary endpoint was defined as technical success (i.e., no conversion to secondary robotic, video-assisted thoracoscopic, or open approaches). Secondary endpoints of interest included post-operative outcomes and complication rates. A meta-analysis using a random effects model of proportions or means was applied, as appropriate.
Results: The search strategy ultimately yielded 12 relevant studies for inclusion. A total of 240 patients (52% male) split across cohort studies and case reports were identified. The mean age of the two groups was 59.7±3.0 and 58.1±6.8 years, respectively. The mean operative time was 133.8±38.2 and 150.0±52.2 minutes, respectively. Length of hospital stay was 4.4±1.6 and 4.3±1.1 days, respectively. The mean blood loss was 80.0±25.1 mL The majority of identified procedures were lobectomies, segmentectomies, and wedge resections, though complex sleeve resections and anterior mediastinal mass resections were also completed. Cumulative technical success was 99.9%.
Conclusions: The uniportal robotic-assisted approach, when completed in expert hands, has been illustrated to have exceedingly low rates of conversion to secondary procedures, along with short length of stay (LOS), minimal blood loss, and short procedural times (variable depending on operation type). Current evidence on the feasibility of this approach will be bolstered by upcoming multi-institutional series.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080331 | PMC |
http://dx.doi.org/10.21037/acs-2023-urats-37 | DOI Listing |
Eur J Cardiothorac Surg
August 2025
Department of Thoracic Surgery, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Bronchial sleeve resection is the preferred technique over pneumonectomy for centrally located tumors, preserving lung function and improving survival. We present a uniportal robotic-assisted thoracic surgery technique for left main bronchus sleeve resection with secondary carinal reconstruction in a patient with a typical carcinoid tumour. Through a single 4 cm incision, the left main bronchus and its bifurcation were resected and reconstructed using a continuous absorbable barbed suture.
View Article and Find Full Text PDFSurg Endosc
August 2025
Department of Surgery, University Hospital Ostrava, 17.Listopadu 1790, Ostrava, Czech Republic.
Background: Minimally invasive thoracic surgery techniques, such as robotic-assisted thoracic surgery (RATS) and uniportal video-assisted thoracoscopic surgery (UVATS), have revolutionized lung cancer treatment. However, comparative data on postoperative pain and functional recovery remain limited. This cohort study evaluates differences in pain intensity and pain-related activity limitations following radical lobectomy for lung cancer.
View Article and Find Full Text PDFThorac Cancer
June 2025
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taiwan.
Background: Uniportal robotic-assisted thoracic surgery (uRATS) has emerged as an innovative minimally invasive approach for lung anatomic resections. This study evaluates the safety, feasibility, and outcomes of uRATS, comparing the original technique with a modified approach utilizing a novel trocar configuration to minimize incision size.
Methods: A retrospective analysis was conducted on 40 patients who underwent uRATS for lung cancer between August 2023 and August 2024 at a tertiary medical center.
World J Surg Oncol
June 2025
Department of Thoracic Surgery II, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, Xinjiang, 830011, China.
Objective: To compare the short-term outcomes of multi-arm uniportal robotic-assisted thoracoscopic surgery (URATS) and multiport robotic-assisted thoracoscopic surgery (MRATS) and to evaluate the safety and feasibility of URATS.
Methods: A retrospective analysis was conducted on clinical data from patients who underwent robotic-assisted thoracoscopic surgery in the Department of Thoracic Surgery II at Xinjiang Tumor Hospital between May 2023 and January 2025. Patients were categorized into the URATS and MRATS groups based on the surgical approach.
Ann Thorac Surg
May 2025
Department of Thoracic Surgery, National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Electronic address:
Background: Robotic-assisted thoracic surgery (RATS) has advanced lung cancer treatment with precise robotic arm maneuvers and 3-dimensional visualization. Whereas conventional RATS systems require multiple incisions, a uniportal approach is increasingly favored. However, current systems face challenges with maneuverability and incision size.
View Article and Find Full Text PDF